Endotherapy Devices Global Market Report 2024

The endotherapy devices market has grown strongly in recent years. It will grow from $4.48 billion in 2023 to $4.76 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%. The expansion observed in the historical period can be ascribed to the increasing incidence of gastrointestinal disorders, a growing aging population, heightened awareness leading to early diagnosis, favorable reimbursement policies, global economic development, and strategic collaborations and partnerships.

The endotherapy devices market is expected to see strong growth in the next few years. It will grow to $6.17 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%. The anticipated expansion in the forecast period can be linked to progress in minimally invasive techniques, the increasing burden of chronic diseases, the broadening of healthcare infrastructure, a heightened emphasis on early detection, regulatory support, and standardization. Noteworthy trends expected in the forecast period encompass advancements in imaging technologies, the incorporation of artificial intelligence, technological progress, the global expansion of healthcare infrastructure, and a rising prevalence of gastrointestinal disorders.

The anticipated growth in the endotherapy devices market is driven by the increasing incidence of gastrointestinal diseases. Gastrointestinal conditions, affecting the digestive tract from the mouth to the anus, encompass ailments such as colorectal cancer, gastroesophageal reflux disease, ulcerative colitis (UC), inflammatory bowel disease (IBD), Crohn's disease (CD), among others. Endotherapy devices play a crucial role in the non-invasive or minimally invasive surgical procedures used to treat and diagnose various gastrointestinal issues, including ulcers, bleeding, celiac disease, obstructions, inflammation, and tumors. They are instrumental in identifying the source of unexplained symptoms such as heartburn, abdominal pain, bleeding, nausea, vomiting, and pain. For example, a January 2021 article by Cleveland Clinic indicated that diverticular disease affects 10% of individuals over 40 and 50% over 60 in Western societies, while colorectal cancer, diagnosed in 130,000 Americans annually, is the second most prevalent cancer in the United States. Thus, the increased incidence of gastrointestinal diseases contributes to the growth of the endotherapy devices market.

The growth of the endotherapy devices market is further fueled by the rising prevalence of obesity. Obesity, characterized by the excessive accumulation of body fat with adverse effects on health, can be effectively managed with endotherapy devices. These devices play a crucial role in weight loss, appetite reduction, improving the quality of life, providing minimally invasive treatment, and offering temporary interventions for obesity management. According to World Obesity, the number of obese individuals is expected to increase to 892 million in 2025 and reach 1,025 million in 2030. In England, it was projected that 25.9% of individuals aged 18 and older were obese in 2021-2022. Consequently, the growing prevalence of obesity is a key driver for the expansion of the endotherapy devices market.

Technological advancements represent a prominent trend in the endotherapy devices market, with major companies actively innovating their products to enhance observational capabilities and maintain market competitiveness. For instance, FUJIFILM Healthcare Americas Corporation, a leading US-based provider of endoscopic imaging and endosurgical solutions, introduced the El-740D/S dual-channel endoscope for gastrointestinal applications in October 2021. Featuring dual channel widths of 3.7mm and 3.2mm, the EI-740D/S incorporates Linked Colour Imaging (LCI) and Blue Light Imaging (BLI) light mode options to improve lesion and adenoma detection and characterization. The endoscope's design facilitates easy insertion and device visualization, with a 210° upward angulation and short bending part for precise maneuverability, enabling observation and treatment in challenging locations.

Major companies in the endotherapy devices market are strategically focusing on innovative products such as endoscopy systems to drive market revenues. An endoscopy system is a minimally invasive medical technology used for internal organ examination. For example, Olympus Corporation, a Japan-based manufacturer of optics and reprography products, launched EVIS X1 in October 2023. Equipped with cutting-edge imaging technologies such as red dichromatic imaging (RDITM) and texture and color enhancement imaging (TXITM), the system enhances visibility and abnormality identification in the gastrointestinal tract. Notable features include a 10% lighter ErgoGrip control section for improved user comfort and scope handling. The introduction of the EVIS X1 endoscopic system reflects Olympus' commitment to advancing endoscopy technology and providing medical professionals with the tools necessary for high-quality treatment.

In May 2021, Olympus Corporation acquired Medi-Tate, an Israel-based medical device manufacturing company specializing in gastroenterological endotherapy devices, urological devices, and respiratory endotherapy devices. This acquisition aims to expand Olympus Corporation's business line in offering in-office treatments such as hyperplasia (BPH) treatment and strengthen its position in the field of urological devices.

Major companies operating in the endotherapy devices market report are Olympus Corporation, Boston Scientific Corporation, Conmed Corporation, Medtronic Plc, Fujifilm Holdings Corporation, Johnson & JohnsonCook Group Incorporated, Karl Storz SE & Co. KG, Stryker Corporation, Siemens Healthcare, Taewoong Medical Co. Ltd., Smith & Nephew Plc., Steris Corporation, Cosmed Corporation, Micro-Tech (Nanjing) Co Ltd., HOYA Corporation, Cook Group Incorporated, B. Braun Melsungen AG, Frontier Healthcare, Advanced Sterilization Products Services Inc., Pentax Medical, Nipro Corporation, MEDIVATORS B.V., The Cooper Companies Inc., US Endoscopy Group Inc., Richard Wolf GmbH, Cantel Medical Corp., Fujinon Corporation, Gyrus ACMI, Cogentix Medical Inc., Endogastric Solutions Inc.

North America as the largest region in the endotherapy devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global endotherapy devices market report during the forecast period. The regions covered in the endotherapy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the endotherapy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary categories of endotherapy devices include gastrointestinal devices and accessories, endoscopic retrograde cholangiopancreatography devices and accessories, and other endotherapy devices. Gastrointestinal devices and accessories are medical tools utilized in the diagnosis and treatment of gastrointestinal (GI) disorders. They play a crucial role in various procedures, including endoscopic examinations that allow visualization and access to the inside of the GI tract, covering areas such as the esophagus, stomach, duodenum, and colon. Additionally, these devices are employed in surgical interventions to deliver targeted therapies directly to affected areas. These devices find extensive applications in bronchoscopy, arthroscopy, laparoscopy, urology endoscopy, neuro-endoscopy, gastrointestinal endoscopy, and other medical procedures performed by hospitals, ambulatory surgical centers, and other end-users.

The endotherapy devices market research report provides endotherapy devices market statistics, including endotherapy devices industry global market size, regional shares, competitors with an endotherapy devices market share, detailed endotherapy devices market segments, market trends and opportunities, and any further data you may need to thrive in the endotherapy devices industry. This endotherapy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The endotherapy devices market consists of sales of devices such as mechanically enhanced colonoscopies, endoscopic hemostasis, tissue sampling devices, metallic stents, dilation balloons, foreign body retrieval devices, electrosurgical needs, and UCR insufflators. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.